Warning: The NCBI web site requires JavaScript to function. more...
High HCV seroprevalence and HIV drug use risk behaviors among injection drug users in Pakistan.
Kuo I, ul-Hasan S, Galai N, Thomas DL, Zafar T, Ahmed MA, Strathdee SA.
Harm Reduct J. 2006 Aug 16;3:26.
Related citations
Modelling the transmission of HIV and HCV among injecting drug users in Rawalpindi, a low HCV prevalence setting in Pakistan.
Vickerman P, Platt L, Hawkes S.
Sex Transm Infect. 2009 Apr;85 Suppl 2:ii23-30. Erratum in: Sex Transm Infect. 2009 Jun;85(3):181.
HIV/AIDS risk behaviors and correlates of injection drug use among drug users in Pakistan.
Ahmed MA, Zafar T, Brahmbhatt H, Imam G, Ul Hassan S, Bareta JC, Strathdee SA.
J Urban Health. 2003 Jun;80(2):321-9.
Prevalence of HIV, HCV and sexually transmitted infections among injecting drug users in Rawalpindi and Abbottabad, Pakistan: evidence for an emerging injection-related HIV epidemic.
Platt L, Vickerman P, Collumbien M, Hasan S, Lalji N, Mayhew S, Muzaffar R, Andreasen A, Hawkes S.
Sex Transm Infect. 2009 Apr;85 Suppl 2:ii17-22.
Using hepatitis C virus and herpes simplex virus-2 to track HIV among injecting drug users in New York City.
Des Jarlais DC, Arasteh K, McKnight C, Hagan H, Perlman D, Friedman SR.
Drug Alcohol Depend. 2009 Apr 1;101(1-2):88-91. Epub 2008 Dec 23.
Prevalence rates and risk factors for hepatitis C among drug users not in treatment in Malaysia.
Vicknasingam B, Narayanan S, Navaratnam V.
Drug Alcohol Rev. 2009 Jul;28(4):447-54.
Coverage to curb the emerging HIV epidemic among injecting drug users in Pakistan: delivering prevention services where most needed.
Emmanuel F, Fatima M.
Int J Drug Policy. 2008 Apr;19 Suppl 1:S59-64. Epub 2008 Feb 20.
Methods to recruit and retain a cohort of young-adult injection drug users for the Third Collaborative Injection Drug Users Study/Drug Users Intervention Trial (CIDUS III/DUIT).
Garfein RS, Swartzendruber A, Ouellet LJ, Kapadia F, Hudson SM, Thiede H, Strathdee SA, Williams IT, Bailey SL, Hagan H, Golub ET, Kerndt P, Hanson DL, Latka MH; DUIT Study Team.
Drug Alcohol Depend. 2007 Nov;91 Suppl 1:S4-17. Epub 2007 Jun 19.
Factors associated with an explosive HIV epidemic among injecting drug users in Sargodha, Pakistan.
Emmanuel F, Archibald C, Razaque A, Sandstrom P.
J Acquir Immune Defic Syndr. 2009 May 1;51(1):85-90.
Injection behaviors among injection drug users in treatment: The role of hepatitis C awareness.
Korthuis PT, Feaster DJ, Gomez ZL, Das M, Tross S, Wiest K, Douaihy A, Mandler RN, Sorensen JL, Colfax G, McCarty D, Cohen SE, Penn PE, Lape D, Metsch LR.
Addict Behav. 2011 Dec 14. [Epub ahead of print]
Greater drug injecting risk for HIV, HBV, and HCV infection in a city where syringe exchange and pharmacy syringe distribution are illegal.
Neaigus A, Zhao M, Gyarmathy VA, Cisek L, Friedman SR, Baxter RC.
J Urban Health. 2008 May;85(3):309-22. Epub 2008 Mar 14.
Rise in needle sharing among injection drug users in Pakistan during the Afghanistan war.
Strathdee SA, Zafar T, Brahmbhatt H, Baksh A, ul Hassan S.
Drug Alcohol Depend. 2003 Jul 20;71(1):17-24.
High-risk sexual behaviours among drug users in Pakistan: implications for prevention of STDs and HIV/AIDS.
Haque N, Zafar T, Brahmbhatt H, Imam G, ul-Hassan S, Strathdee SA.
J Pak Med Assoc. 2006 Jan;56(1 Suppl 1):S65-72.
The influence of needle exchange programs on injection risk behaviors and infection with hepatitis C virus among young injection drug users in select cities in the United States, 1994-2004.
Holtzman D, Barry V, Ouellet LJ, Des Jarlais DC, Vlahov D, Golub ET, Hudson SM, Garfein RS.
Prev Med. 2009 Aug;49(1):68-73. Epub 2009 May 4.
Comparison of injecting drug users who obtain syringes from pharmacies and syringe exchange programs in Tallinn, Estonia.
Vorobjov S, Uusküla A, Abel-Ollo K, Talu A, Rüütel K, Des Jarlais DC.
Harm Reduct J. 2009 Feb 20;6:3.
Risk of hepatitis C infection among injection drug users in Mizoram, India.
Chelleng PK, Borkakoty BJ, Chetia M, Das HK, Mahanta J.
Indian J Med Res. 2008 Nov;128(5):640-6.
Integrating multiple programme and policy approaches to hepatitis C prevention and care for injection drug users: a comprehensive approach.
Birkhead GS, Klein SJ, Candelas AR, O'Connell DA, Rothman JR, Feldman IS, Tsui DS, Cotroneo RA, Flanigan CA.
Int J Drug Policy. 2007 Oct;18(5):417-25. Epub 2007 Feb 20. Review.
Incidence and risk factors for hepatitis C seroconversion in injecting drug users in Australia.
Maher L, Jalaludin B, Chant KG, Jayasuriya R, Sladden T, Kaldor JM, Sargent PL.
Addiction. 2006 Oct;101(10):1499-508.
Prevalence of hepatitis B and C among HIV positive patients in Georgia and its associated risk factors.
Badridze N, Chkhartishvili N, Abutidze A, Gatserelia L, Sharvadze L.
Georgian Med News. 2008 Dec;(165):54-60.
Injecting and sexual risk correlates of HBV and HCV seroprevalence among new drug injectors.
Neaigus A, Gyarmathy VA, Miller M, Frajzyngier V, Zhao M, Friedman SR, Des Jarlais DC.
Drug Alcohol Depend. 2007 Jul 10;89(2-3):234-43. Epub 2007 Feb 7.
Filter your results:
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on